Growth Metrics

908 Devices (MASS) Cash & Equivalents Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -9.44%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 19.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -36.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 40.99%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.52%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -0.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.25%
10 908 Devices 314.43 Mn 202.69 Mn 6.88 Mn -25.17%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -25.17%
Dec 31, 2025 -27.94%
Sep 30, 2025 -31.30%
Jun 30, 2025 -33.82%
Mar 31, 2025 -29.21%
Dec 31, 2024 -41.86%
Sep 30, 2024 -31.29%
Jun 30, 2024 -30.81%
Mar 31, 2024 -11.12%
Dec 31, 2023 -8.73%
Sep 30, 2023 81.68%
Jun 30, 2023 127.23%
Mar 31, 2023 122.39%